Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

18.95
Delayed Data
As of Oct 20
 -0.18 / -0.94%
Today’s Change
7.61
Today|||52-Week Range
27.09
+91.03%
Year-to-Date

Today’s Trading

Previous close19.13
Today’s open19.48
Day’s range18.86 - 19.68
Volume438,884
Average volume (3 months)943,633
Market cap$899.1M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+20.97%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.13-0.45%
BYSIBeyondspring Inc-6.01-17.17%
ATNXAthenex Inc+0.05+0.29%
ZIOPZIOPHARM Oncology In...-0.23-4.09%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts